Price $38.38 |
Market Cap
716.4M
|
Sector Health Care |
Div. Growth
15.20%
|
|
P/E
53.8
|
P/B
7.16
|
P/S
7.3
|
Dividend %
0.60%
|
|
P/CF
870.7
|
P/FCF
61.5
|
Op. Cash Flow
18.4K
|
FCF
0.6
|
|
Op. Margin
19.70%
|
Net Margin
14.20%
|
ROE
15.00%
|
ROI
12.20%
|
|
ROA
13.00%
|
EPS Growth
42.10%
|
Current Ratio
5.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostar Pharmaceuticals Inc (BSPM) | $1.74 | - | - | 3.5M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.72 | - | - | 25.1M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.52 | - | - | 4.5M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.82 | - | - | 14.3M | Strong Buy |
| DURECT Corporation (DRRX) | $1.97 | - | - | 258.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
